Simulations Plus (NASDAQ:SLP) Releases Earnings Results, Beats Expectations By $0.04 EPS

Simulations Plus (NASDAQ:SLP) announced its quarterly earnings data on Tuesday. The technology company reported $0.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.15 by $0.04, Briefing.com reports. Simulations Plus had a net margin of 14.36% and a return on equity of 7.80%. The firm had revenue of $18.54 million during the quarter, compared to analyst estimates of $17.92 million. During the same quarter in the prior year, the firm posted $0.20 earnings per share. Simulations Plus’s quarterly revenue was up 14.2% on a year-over-year basis. Simulations Plus updated its FY24 guidance to $0.54-0.56 EPS and its FY 2024 guidance to 0.540-0.560 EPS.

Simulations Plus Stock Performance

Shares of SLP opened at $39.89 on Friday. The stock has a market capitalization of $797.40 million, a PE ratio of 75.26 and a beta of 0.72. Simulations Plus has a 1 year low of $32.69 and a 1 year high of $52.69. The company’s 50-day simple moving average is $47.56 and its 200-day simple moving average is $44.12.

Simulations Plus Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, August 5th. Stockholders of record on Monday, July 29th will be given a dividend of $0.06 per share. The ex-dividend date is Monday, July 29th. This represents a $0.24 annualized dividend and a dividend yield of 0.60%. Simulations Plus’s dividend payout ratio is presently 45.28%.

Wall Street Analyst Weigh In

Several research analysts have weighed in on SLP shares. William Blair started coverage on shares of Simulations Plus in a research note on Friday, June 28th. They set an “outperform” rating for the company. Craig Hallum reaffirmed a “buy” rating and set a $56.00 target price on shares of Simulations Plus in a research note on Wednesday. Finally, Oppenheimer increased their target price on shares of Simulations Plus from $55.00 to $65.00 and gave the stock an “outperform” rating in a research note on Thursday, June 13th.

Insider Transactions at Simulations Plus

In other news, Director Daniel L. Weiner sold 3,250 shares of the stock in a transaction dated Tuesday, May 7th. The shares were sold at an average price of $48.31, for a total transaction of $157,007.50. Following the sale, the director now owns 8,759 shares of the company’s stock, valued at $423,147.29. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, Director Daniel L. Weiner sold 750 shares of the firm’s stock in a transaction that occurred on Friday, June 28th. The shares were sold at an average price of $49.32, for a total value of $36,990.00. Following the sale, the director now owns 7,009 shares of the company’s stock, valued at $345,683.88. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Daniel L. Weiner sold 3,250 shares of the firm’s stock in a transaction that occurred on Tuesday, May 7th. The shares were sold at an average price of $48.31, for a total transaction of $157,007.50. Following the completion of the sale, the director now directly owns 8,759 shares in the company, valued at approximately $423,147.29. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 44,500 shares of company stock valued at $2,072,198. 20.90% of the stock is currently owned by corporate insiders.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.